Developer docs
API playgroundTry for free, no card

Search company profiles

NantWorks

Full company profile

uuid003v7np

Namestring
NantWorks
Legal namestring
NantWorks, LLC
Websiteurl
nantworks.com
Company typeenum
Private
Founded yearint
2010
Descriptiontext

NantWorks, LLC is a privately held Delaware-formed holding company founded by Dr. Patrick Soon-Shiong, the scientist-inventor of Abraxane (the first human nanoparticle chemotherapeutic agent). The company functions as the parent entity over a family of private and public affiliates organized around three strategic pillars: health and life sciences, energy and renewables, and connectivity and communications. Its stated mission is "convergence" — applying multiple technology streams simultaneously to accelerate innovation, broaden scientific discovery, and improve healthcare treatment.

NantWorks' underlying technology portfolio spans next-generation machine vision, object and voice recognition, ultra-low power semiconductors, supercomputing, and advanced networks. These technology streams are positioned for application across healthcare, commerce, and digital entertainment. Public-facing materials describe the offering as a platform-plus-technologies model in which the parent orchestrates capability development across affiliates rather than delivering a single product. The company maintains a headquarters at 450 Duley Rd, El Segundo, CA and an additional legal department office at 9920 Jefferson Blvd., Culver City, CA.

The business model is not publicly disclosed: there is no pricing information, no published revenue, no disclosed headcount, no external funding rounds, and no named customer logos in the available source data. NantWorks is described in qualitative terms only — as a holding-company parent that derives value from convergence across its three pillars. As such, monetization mechanics at the parent level are opaque; commercial activity, if any, appears to reside primarily within the subsidiary entities rather than at the LLC parent itself.

Short descriptiontext

NantWorks, LLC is a privately held parent holding company founded by Dr. Patrick Soon-Shiong that oversees a family of private and public entities focused on health and life sciences, energy and renewables, and connectivity and communications.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersCulver City, United States
HQ citystring
Culver City
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
convergence technology platforms, machine vision systems, low power semiconductors, supercomputing infrastructure, healthcare technology solutions
Industry4 codes
PRIMARYHDAAACAG
Multimodal Generation (Text-Image-Video-Audio) & Creative Toolchains
Hardware, Technology & Telecom/Artificial Intelligence & Machine Learning/Foundation Models & Generative AI (LLMs, multimodal)
SECONDARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHDAIAFAH
Secure Access Service Edge (SASE) & Secure SD-WAN
Hardware, Technology & Telecom/Telecommunications & Network Services/Data & IP Network Services (MPLS, SD-WAN, Ethernet)
SECONDARYHDAHAKAG
Embedded & Managed NAND (eMMC/UFS/eMCP)
Hardware, Technology & Telecom/Semiconductors & Electronic Components/Memory & Storage ICs (DRAM/NAND/Controllers)
NAICS code2 codes
  • Computer and Peripheral Equipment Manufacturing33411
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services518
SIC code1 code
  • Electronic Computers3571
Product category
Convergence Technology Holdings
Social media profiles2 records
Cost components3 values
Technology or R&D, Personnel, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

NantWorks, LLC is a parent company that develops and delivers a diverse range of convergence technologies through a family of private and public entities, focusing on three pillars: health & life sciences, energy & renewables, and connectivity & communications. Its core technology areas include next-generation machine vision, object and voice recognition, ultra-low power semiconductors, supercomputing, and advanced networks, aimed at bringing the digital revolution to healthcare, commerce, and digital entertainment.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

NantWorks, LLC is a parent company operating a platform-plus-technologies portfolio organized around three strategic pillars: health & life sciences, energy & renewables, and connectivity & communications. The company develops and delivers a diverse range of technologies through its family of private and public entities, including machine vision, object and voice recognition technologies, ultra-low power semiconductors, supercomputing solutions, and advanced networks. The portfolio is unified by a convergence mission to accelerate innovation and bring digital revolution to healthcare, commerce, and digital entertainment. Founded by Dr. Patrick Soon-Shiong, inventor of Abraxane, the company leverages scientific expertise across its technology offerings.

Product and service7 records
1NantWorks Parent Platform
CategoryConvergence Technology Platform
Description

Parent company platform applying innovative approaches and technologies across three core pillars: health & life sciences, energy & renewables, and connectivity & communications, with a mission of convergence to accelerate innovation and improve healthcare treatment. Audience: organizations and businesses seeking advanced technology solutions across multiple sectors.

2Machine Vision Technologies
CategoryMachine Vision Technology
Description

Next-generation machine vision technologies developed by NantWorks enabling digital transformation across healthcare, commerce, and digital entertainment sectors.

3Voice Recognition Technologies
CategoryVoice Recognition Technology
Description

Advanced voice recognition technologies integrated within NantWorks' portfolio for applications in healthcare, commerce, and digital entertainment.

4Object Recognition Technologies
CategoryObject Recognition Technology
Description

Object recognition technologies developed by NantWorks to enable digital revolution applications across multiple industry sectors.

5Ultra-Low Power Semiconductors
CategorySemiconductor Technology
Description

Custom semiconductor technologies developed by NantWorks to power advanced computing and connectivity solutions with reduced energy consumption.

6Supercomputing Solutions
CategoryHigh-Performance Computing
Description

Supercomputing capabilities deployed by NantWorks to support advanced research, scientific discovery, and complex computational needs across health and life sciences applications.

7Advanced Networks
CategoryNetwork Infrastructure
Description

Advanced networking infrastructure developed by NantWorks to enable high-speed connectivity and communication solutions across multiple sectors.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
1Cognex
TypeDirect peer
Description

Specialized machine vision company serving industrial, logistics, and medical-imaging applications — a focused competitor to NantWorks' machine vision technology pillar.

TypeBroad incumbent
Description

Parent holding company of Google, Verily, and Waymo operating across AI, healthcare/life sciences, and connectivity — the closest large-scale analog to NantWorks' convergence-of-frontier-tech holding model.

TypeDirect peer
Description

Healthcare technology subsidiary founded by Dr. Soon-Shiong delivering AI-driven clinical decision support — a sister NantWorks entity and the clearest commercial peer within the life sciences pillar.

4Tempus Labs
TypeDirect peer
Description

AI-driven precision medicine and genomics company applying machine learning and supercomputing to clinical and research workflows — a direct competitor within NantWorks' primary health & life sciences pillar.

TypeBroad incumbent
Description

Diversified technology incumbent with Watson Health, advanced semiconductors, and supercomputing offerings — comparable as a broad incumbent operating across healthcare AI, compute infrastructure, and enterprise networks.

TypeDirect peer
Description

Clinical-stage immunotherapy company founded and led by Dr. Patrick Soon-Shiong; comparable because it shares the same founder and a closely aligned mission of convergence-driven biotech innovation.

TypeBroad incumbent
Description

Dominant provider of supercomputing hardware and AI platforms increasingly applied to healthcare, life sciences, and edge networking — overlaps with NantWorks' supercomputing, vision, and ultra-low-power semiconductor pillars.

TypeEmerging player
Description

Developer of ultra-low power, high-efficiency server and edge semiconductors — a comparable specialized competitor within NantWorks' custom ultra-low power semiconductor pillar.

TypeDirect peer
Description

Life sciences platform combining AI, machine vision, sensors, and advanced compute — directly mirrors NantWorks' healthcare pillar strategy and convergence of biotech with frontier compute.

TypeDirect peer
Description

Voice recognition and conversational AI company serving automotive, healthcare, and commerce — directly comparable to NantWorks' voice recognition technology offering.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment13 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NantWorks

Convergence Technology Holdingsnantworks.com

NantWorks, LLC is a privately held parent holding company founded by Dr. Patrick Soon-Shiong that oversees a family of private and public entities focused on health and life sciences, energy and renewables, and connectivity and communications.

What NantWorks does

NantWorks, LLC is a privately held Delaware-formed holding company founded by Dr. Patrick Soon-Shiong, the scientist-inventor of Abraxane (the first human nanoparticle chemotherapeutic agent). The company functions as the parent entity over a family of private and public affiliates organized around three strategic pillars: health and life sciences, energy and renewables, and connectivity and communications. Its stated mission is "convergence" — applying multiple technology streams simultaneously to accelerate innovation, broaden scientific discovery, and improve healthcare treatment.

NantWorks' underlying technology portfolio spans next-generation machine vision, object and voice recognition, ultra-low power semiconductors, supercomputing, and advanced networks. These technology streams are positioned for application across healthcare, commerce, and digital entertainment. Public-facing materials describe the offering as a platform-plus-technologies model in which the parent orchestrates capability development across affiliates rather than delivering a single product. The company maintains a headquarters at 450 Duley Rd, El Segundo, CA and an additional legal department office at 9920 Jefferson Blvd., Culver City, CA.

The business model is not publicly disclosed: there is no pricing information, no published revenue, no disclosed headcount, no external funding rounds, and no named customer logos in the available source data. NantWorks is described in qualitative terms only — as a holding-company parent that derives value from convergence across its three pillars. As such, monetization mechanics at the parent level are opaque; commercial activity, if any, appears to reside primarily within the subsidiary entities rather than at the LLC parent itself.

NantWorks firmographics

Firmographics
Name
NantWorks
Legal name
NantWorks, LLC
Website
https://nantworks.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
NantWorks, LLC is a privately held parent holding company founded by Dr. Patrick Soon-Shiong that oversees a family of private and public entities focused on health and life sciences, energy and renewables, and connectivity and communications.
Ownership category
akta.pro rank

NantWorks industry classification

Industry
Product category
Convergence Technology Holdings
NAICS
Computer and Peripheral Equipment Manufacturing (33411), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)
SIC
Electronic Computers (3571)
akta.pro industry
PRIMARYHDAAACAG
Multimodal Generation (Text-Image-Video-Audio) & Creative Toolchains
Hardware, Technology & Telecom/Artificial Intelligence & Machine Learning/Foundation Models & Generative AI (LLMs, multimodal)
SECONDARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHDAIAFAH
Secure Access Service Edge (SASE) & Secure SD-WAN
Hardware, Technology & Telecom/Telecommunications & Network Services/Data & IP Network Services (MPLS, SD-WAN, Ethernet)
SECONDARYHDAHAKAG
Embedded & Managed NAND (eMMC/UFS/eMCP)
Hardware, Technology & Telecom/Semiconductors & Electronic Components/Memory & Storage ICs (DRAM/NAND/Controllers)

Keywords

  • Convergence technology platforms
  • Machine vision systems
  • Low power semiconductors
  • Supercomputing infrastructure
  • Healthcare technology solutions

Where NantWorks is headquartered

Location

Headquarters

HQ city
Culver City
HQ country
United States
HQ region
North America

Offices2 records

Markets served

NantWorks business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations

NantWorks product offering

Product offering

Core offering

NantWorks, LLC is a parent company that develops and delivers a diverse range of convergence technologies through a family of private and public entities, focusing on three pillars: health & life sciences, energy & renewables, and connectivity & communications. Its core technology areas include next-generation machine vision, object and voice recognition, ultra-low power semiconductors, supercomputing, and advanced networks, aimed at bringing the digital revolution to healthcare, commerce, and digital entertainment.

Product overview

NantWorks, LLC is a parent company operating a platform-plus-technologies portfolio organized around three strategic pillars: health & life sciences, energy & renewables, and connectivity & communications. The company develops and delivers a diverse range of technologies through its family of private and public entities, including machine vision, object and voice recognition technologies, ultra-low power semiconductors, supercomputing solutions, and advanced networks. The portfolio is unified by a convergence mission to accelerate innovation and bring digital revolution to healthcare, commerce, and digital entertainment. Founded by Dr. Patrick Soon-Shiong, inventor of Abraxane, the company leverages scientific expertise across its technology offerings.

Differentiator

Problem solved

Functional benefit

Products and services

  • NantWorks Parent Platform Parent company platform applying innovative approaches and technologies across three core pillars: health & life sciences, energy & renewables, and connectivity & communications, with a mission of convergence to accelerate innovation and improve healthcare treatment. Audience: organizations and businesses seeking advanced technology solutions across multiple sectors.
  • Machine Vision Technologies Next-generation machine vision technologies developed by NantWorks enabling digital transformation across healthcare, commerce, and digital entertainment sectors.
  • Voice Recognition Technologies Advanced voice recognition technologies integrated within NantWorks' portfolio for applications in healthcare, commerce, and digital entertainment.
  • Object Recognition Technologies Object recognition technologies developed by NantWorks to enable digital revolution applications across multiple industry sectors.
  • Ultra-Low Power Semiconductors Custom semiconductor technologies developed by NantWorks to power advanced computing and connectivity solutions with reduced energy consumption.
  • Supercomputing Solutions Supercomputing capabilities deployed by NantWorks to support advanced research, scientific discovery, and complex computational needs across health and life sciences applications.
  • Advanced Networks Advanced networking infrastructure developed by NantWorks to enable high-speed connectivity and communication solutions across multiple sectors.

Companies that use NantWorks

Customer profile

Segments3 records

Ideal customer profiles3 records

NantWorks technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

NantWorks partnerships and signals

Strategic signal

Recent moves3 records

Expansion highlights3 records

NantWorks competitors and assessment

Company assessment

Direct peers

  • Cognex: Specialized machine vision company serving industrial, logistics, and medical-imaging applications — a focused competitor to NantWorks' machine vision technology pillar.
  • NantHealth: Healthcare technology subsidiary founded by Dr. Soon-Shiong delivering AI-driven clinical decision support — a sister NantWorks entity and the clearest commercial peer within the life sciences pillar.
  • Tempus Labs: AI-driven precision medicine and genomics company applying machine learning and supercomputing to clinical and research workflows — a direct competitor within NantWorks' primary health & life sciences pillar.
  • ImmunityBio: Clinical-stage immunotherapy company founded and led by Dr. Patrick Soon-Shiong; comparable because it shares the same founder and a closely aligned mission of convergence-driven biotech innovation.
  • Verily (Alphabet subsidiary): Life sciences platform combining AI, machine vision, sensors, and advanced compute — directly mirrors NantWorks' healthcare pillar strategy and convergence of biotech with frontier compute.
  • SoundHound AI: Voice recognition and conversational AI company serving automotive, healthcare, and commerce — directly comparable to NantWorks' voice recognition technology offering.

Broad incumbents

  • Alphabet: Parent holding company of Google, Verily, and Waymo operating across AI, healthcare/life sciences, and connectivity — the closest large-scale analog to NantWorks' convergence-of-frontier-tech holding model.
  • IBM: Diversified technology incumbent with Watson Health, advanced semiconductors, and supercomputing offerings — comparable as a broad incumbent operating across healthcare AI, compute infrastructure, and enterprise networks.
  • NVIDIA: Dominant provider of supercomputing hardware and AI platforms increasingly applied to healthcare, life sciences, and edge networking — overlaps with NantWorks' supercomputing, vision, and ultra-low-power semiconductor pillars.

Emerging players

  • Ampere Computing: Developer of ultra-low power, high-efficiency server and edge semiconductors — a comparable specialized competitor within NantWorks' custom ultra-low power semiconductor pillar.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

NantWorks social profiles

Digital presence

NantWorks financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NantWorks leadership team

Management profile

Number of profiles

Profiles1 record

NantWorks funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NantWorks M&A and investment

M&A and investment

M&A2 records

Investments13 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NantWorks

What does NantWorks do?

NantWorks, LLC is a parent company that develops and delivers a diverse range of convergence technologies through a family of private and public entities, focusing on three pillars: health & life sciences, energy & renewables, and connectivity & communications. Its core technology areas include next-generation machine vision, object and voice recognition, ultra-low power semiconductors, supercomputing, and advanced networks, aimed at bringing the digital revolution to healthcare, commerce, and digital entertainment.

Is NantWorks a public or private company?

NantWorks is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was NantWorks founded?

NantWorks was founded in 2010. It employs 1,001 to 5,000 people.

Where is NantWorks based?

NantWorks is headquartered in Culver City, United States, in the North America region.

Who are NantWorks's main competitors?

Direct peers on record are Cognex, NantHealth, Tempus Labs, ImmunityBio, Verily (Alphabet subsidiary) and SoundHound AI. Broad incumbents are Alphabet, IBM and NVIDIA. Ampere Computing is listed as an emerging player.

Does NantWorks have an API?

No public API is recorded for NantWorks.

What industry is NantWorks in?

NantWorks's product category is Convergence Technology Holdings. Its primary akta.pro industry code is HDAAACAG, Multimodal Generation (Text-Image-Video-Audio) & Creative Toolchains, with a secondary code of HLAGANAA, Genomics & Next-Generation Sequencing (NGS) Services. Its NAICS code is 33411 and its SIC code is 3571.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business & FinancialIBRX Stock Eyes Best Year Ever: Founder Teases 12 Months Of 'Stealth' Nantworks Reveals - Cancer Tech, AI Chips And SatellitesPatrick Soon-Shiong announced plans to unveil privately funded NantWorks projects over 12 months, including cancer tech, AI chips, and satellites. ImmunityBio shares rose 195% this year, and the company reported Q3 net product revenue of $48.7 million, up 53% year-over-year. A Phase 2 trial of Anktiva in sepsis patients is planned.YahooPDS Biotech Announces Exercise of Warrants by NantWorks for Approximately $3.9 Million in Gross ProceedsNantWorks exercised its outstanding PDS Biotech warrants to buy 17,699,115 shares at $0.22 each, generating about $3.9 million in gross proceeds. The company will use the net proceeds, plus September 2026 private placement funds, to advance PDS0301 toward a Phase 3 trial in metastatic colorectal cancer and support its partnership strategy for PDS0101.News-MedicalProlific announces major new investments and partnerships with NantWorks and Zylidac Bio CDMOProlific Machines announced a partnership with Zylidac Bio CDMO to scale its Optogentics-enabled cell lines for clinical and GMP manufacturing. The company also received an investment led by Atoms & Bits and Nant Capital to expand its optogenetics platform. The funding will support team growth, technology development, and early work toward tissue and organ fabrication.FiercePharmaNantWorks' Soon-Shiong puts chips behind manufacturing disruptors in new rounds for Prolific Machines, Multiply LabsProlific Machines closed a $50 million Series B2 round led by NantWorks and Atoms & Bits, bringing total funding to over $100 million. Multiply Labs raised $75 million in a Series B, also led by NantWorks. Both companies will use the funds to scale their biomanufacturing platforms.Business InsiderHere's the pitch deck a robotics startup used to raise $75 million to automate drug manufacturing.Multiply Labs, a San Francisco robotics startup, raised $75 million in a Series B round led by NantWorks, bringing total funding to over $100 million since 2016. The company automates drug manufacturing for gene therapies and mRNA, with each robot costing several million dollars. It aims to scale from a small customer base to a broader manufacturing business.Medical Device NetworkSHINE Technologies receives EU CMA for Ilumira Lu-177 radioisotopeSHINE Technologies received EU centralised marketing authorisation for its Ilumira non-carrier-added lutetium-177 radioisotope, enabling sales across the European Union. The clearance supports targeted radioligand therapies, and the company also acquired a US isotope manufacturing operation. Ilumira is produced at its Cassiopeia facility in Wisconsin.TechbuzzShine Raises $240 Million to Commercialize FusionSHINE Technologies has raised $240 million in equity funding, bringing its total capital raised to over $1 billion, with the round led by NantWorks and participation from Fidelity Management & Research Company, Sumitomo Corporation of Americas, Pelican Energy Partners, Deerfield Management, and Oaktree Capital Management. The company is commercializing fusion technology through neutron generation systems used for testing aerospace and defense components and producing medical isotopes like Lu-177 for cancer treatment, with capacity to produce up to 100,000 doses annually and plans to scale to 200,000. SHINE's Ilumira product has shipped to 19 countries since launching commercially in 2024, and the company is also developing nuclear waste recycling technology while pursuing commercial fusion energy as a longer-term ambition.VC News DailySHINE Lands $240 Million in FundingSHINE Technologies, a nuclear fusion company headquartered in Janesville, Wisconsin, announced it has raised $240 million in equity funding. The round was led by NantWorks with participation from Fidelity Management & Research Company, Sumitomo Corporation of Americas, Pelican Energy Partners, Deerfield Management, and Oaktree Capital Management, along with other existing investors.YahooSHINE Raises $240 Million in Funding to Advance Commercial Fusion TechnologyWisconsin-based nuclear fusion company SHINE Technologies raised $240 million in equity funding, with the round led by NantWorks and participation from Fidelity, Sumitomo Corp. of Americas, Pelican Energy Partners, Deerfield Management, and Oaktree Capital Management. The funding will advance commercial fusion technology, neutron testing for defense and aerospace, and Lu-177 radioisotope production for targeted cancer therapies, while also supporting development of nuclear fuel recycling. Dr. Patrick Soon-Shiong, founder of NantWorks and prominent biotech entrepreneur, joined SHINE's board as part of the deal, which brings the company's total funding raised to over $1 billion.PR NewswireSHINE Completes $240 Million in Recent Funding Led by Dr. Patrick Soon-Shiong, Founder of NantWorks, Who Joins Board of DirectorsSHINE Technologies, a nuclear fusion company headquartered in Wisconsin, has raised $240 million in equity funding led by Dr. Patrick Soon-Shiong through his investment entity NantWorks, with participation from Fidelity Management & Research Company, Sumitomo Corporation of Americas, Pelican Energy Partners, Deerfield Management, and Oaktree Capital Management. Dr. Soon-Shiong has joined SHINE's Board of Directors, and the two companies have entered a strategic partnership that includes priority access arrangements for Lu-177 supply, a radioisotope used in targeted cancer therapies. The funding will advance SHINE's neutron testing services for defense and aerospace, its medical isotope production for cancer treatment and diagnostic imaging, and its longer-term goals of recycling used nuclear fuel and achieving commercial fusion energy production.